MAP 2018 – Molecular Analysis for Personalised Therapy

Paris, France - 14 Sep - 15 Sep 2018

MAP 2018 – Molecular Analysis for Personalised Therapy is a one-of-a-kind meeting designed by a faculty of highly influential key opinion leaders. A truly unique programme will feature speakers with the highest publication track record in the field. 

MAP 2018 will be the place to network with the leading academic representatives working in personalised medicine for cancer patients.

MAP 2018 is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.

The meeting is highly recommended for medical oncologists, young professionals, academics, regulators, industry R&D representatives and investigators and all those interested in discussing the clinical interpretation of molecular tests with a view to providing effective cancer treatment.

We look forward to see you in Paris in 2018!

Important Deadlines

Deadline Date
Early registration deadline Until 4 July 2018
Late registration deadline and closure of the online registration system Until 22 August 2018
Full registration fee From 23 August 2018

Congress Venue

Paris Marriott Rive Gauche Hotel and Conference Center
17 Boulevard Saint-Jacques
75014 Paris, France

Scientific Chairs

  • Fabrice André, Villejuif, France
  • John Haanen, Amsterdam, The Netherlands
  • Charlie Swanton, London, UK

Organising Committee

European Society for Medical Oncology
UNICANCER
Cancer Research UK

Founders

  • Fabrice André, Institute Gustave Roussy, Villejuif, France
  • Charles Swanton, The Francis Crick Institute, London, UK

Contact

Alessia Mora and Concetta Di Parenti
Tel: +41 (0)91 973 19 47
Fax: +41 (0)91 973 19 18
E-mail symposia@esmo.org